Literature DB >> 1700932

Comparative effects of doxorubicin and 4'-epi-doxorubicin on nucleic acid metabolism and cytotoxicity in a human tumor cell line.

O Cantoni1, P Sestili, F Cattabeni, C Geroni, F Giuliani.   

Abstract

The effects of 4'-epi-doxorubicin (4'E-Dx) and doxorubicin (Dx) on cell survival were investigated after treatments for 1 or 24 h. It was found that after short-term exposure, 4'E-Dx causes a higher level of killing than Dx, whereas a similar cytotoxic response is detectable after 24 h. Under the same experimental conditions (treatment for 1 or 24 h) at equimolar concentrations, the two anthracyclines were equally inhibitory to DNA or RNA synthesis. Both the degree and the rate of induction of DNA strand breakage over a 1-h drug exposure were higher for 4'E-Dx than for Dx. These data were related to results of experiments carried out to investigate the rates of uptake and egress of the anthracyclines. From this study we concluded that no relationship can be established between the cytotoxicity of 4'E-Dx and Dx and their ability to inhibit DNA and RNA synthesis. In addition, the different DNA-damaging action of the two drugs does not appear to be solely dependent on the different rates of cellular uptake.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700932     DOI: 10.1007/bf00689275

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  14 in total

1.  Synthesis and antitumor properties of new glycosides of daunomycinone and adriamycinone.

Authors:  F Arcamone; S Penco; A Vigevani; S Redaelli; G Franchi; A DiMarco; A M Casazza; T Dasdia; F Formelli; A Necco; C Soranzo
Journal:  J Med Chem       Date:  1975-07       Impact factor: 7.446

2.  Cellular and molecular pharmacology of 4'-epidoxorubicin in HeLa cells. Comparison with its parent drug, doxorubicin.

Authors:  O Cantoni; P Sestili; F Cattabeni; C Geroni; M Grandi; F C Giuliani
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

3.  Lethal effect of adriamycin on the division cycle of HeLa cells.

Authors:  S H Kim; J H Kim
Journal:  Cancer Res       Date:  1972-02       Impact factor: 12.701

4.  Inhibition of DNA and RNA metabolism by daunorubicin and adriamycin in L1210 mouse leukemia.

Authors:  W D Meriwether; N R Bachur
Journal:  Cancer Res       Date:  1972-06       Impact factor: 12.701

5.  Pharmacological studies of 3'-(4-morpholinyl)-3'-deaminodaunorubicin in human colon carcinoma cells in vitro.

Authors:  J B Johnston; R I Glazer
Journal:  Cancer Res       Date:  1983-03       Impact factor: 12.701

6.  Structure-activity relationships of anthracyclines relative to effects on macromolecular syntheses.

Authors:  S T Crooke; V H Duvernay; L Galvan; A W Prestayko
Journal:  Mol Pharmacol       Date:  1978-03       Impact factor: 4.436

7.  Cytokinetic and biochemical effects of 5-iminodaunorubicin in human colon carcinoma in culture.

Authors:  R I Glazer; K D Hartman; C L Richardson
Journal:  Cancer Res       Date:  1982-01       Impact factor: 12.701

8.  Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II.

Authors:  K M Tewey; T C Rowe; L Yang; B D Halligan; L F Liu
Journal:  Science       Date:  1984-10-26       Impact factor: 47.728

9.  5-Iminodaunorubicin. Reduced cardiotoxic properties in an antitumor anthracycline.

Authors:  G L Tong; D W Henry; E M Acton
Journal:  J Med Chem       Date:  1979-01       Impact factor: 7.446

10.  Cellular pharmacology of 3'-(4-morpholinyl) and 3'-(4-methoxy-1-piperidinyl) derivatives of 3'-deaminodaunorubicin in human colon carcinoma cells in vitro.

Authors:  J B Johnston; R I Glazer
Journal:  Cancer Res       Date:  1983-04       Impact factor: 12.701

View more
  4 in total

1.  Dose dependence of the cytokinetic and cytotoxic effects of epirubicin in vitro.

Authors:  D Bartkowiak; J Hemmer; E Röttinger
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 2.  Epirubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy.

Authors:  G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

Review 3.  Clinical pharmacokinetics of epirubicin.

Authors:  J Robert
Journal:  Clin Pharmacokinet       Date:  1994-06       Impact factor: 6.447

4.  Effects of antibiotic antitumor drugs on nucleotide levels in cultured tumor cells: an exploratory method to distinguish the mechanisms of antitumor drug action based on targeted metabolomics.

Authors:  Fang Wang; Xi Liu; Cuichai Liu; Zheng Liu; Lixin Sun
Journal:  Acta Pharm Sin B       Date:  2015-04-08       Impact factor: 11.413

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.